CN104312981A - 脊髓灰质炎灭活疫苗及其生产方法 - Google Patents
脊髓灰质炎灭活疫苗及其生产方法 Download PDFInfo
- Publication number
- CN104312981A CN104312981A CN201410570519.3A CN201410570519A CN104312981A CN 104312981 A CN104312981 A CN 104312981A CN 201410570519 A CN201410570519 A CN 201410570519A CN 104312981 A CN104312981 A CN 104312981A
- Authority
- CN
- China
- Prior art keywords
- virus
- poliovirus
- culture
- cell
- inoculation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- 208000000474 Poliomyelitis Diseases 0.000 title abstract description 9
- 229940031551 inactivated vaccine Drugs 0.000 title abstract description 5
- 241000700605 Viruses Species 0.000 claims abstract description 96
- 210000003501 vero cell Anatomy 0.000 claims abstract description 37
- 239000001963 growth medium Substances 0.000 claims abstract description 23
- 239000005723 virus inoculator Substances 0.000 claims abstract description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001301 oxygen Substances 0.000 claims abstract description 18
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 18
- 238000011081 inoculation Methods 0.000 claims abstract description 12
- 238000012258 culturing Methods 0.000 claims abstract description 7
- 241000991587 Enterovirus C Species 0.000 claims description 78
- 229960001539 poliomyelitis vaccine Drugs 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 22
- 210000004027 cell Anatomy 0.000 claims description 21
- 238000003306 harvesting Methods 0.000 claims description 19
- 239000002609 medium Substances 0.000 claims description 16
- 230000010261 cell growth Effects 0.000 claims description 15
- 230000010412 perfusion Effects 0.000 claims description 14
- 238000012423 maintenance Methods 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 230000003612 virological effect Effects 0.000 claims description 11
- 238000004113 cell culture Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000010899 nucleation Methods 0.000 claims description 6
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 239000000427 antigen Substances 0.000 abstract description 10
- 102000036639 antigens Human genes 0.000 abstract description 10
- 108091007433 antigens Proteins 0.000 abstract description 10
- 239000011159 matrix material Substances 0.000 abstract description 10
- 239000000243 solution Substances 0.000 abstract description 8
- 238000005406 washing Methods 0.000 abstract description 3
- 239000012266 salt solution Substances 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 13
- 229960005486 vaccine Drugs 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 6
- 229940029583 inactivated polio vaccine Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000005727 virus proliferation Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 4
- 206010021703 Indifference Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000274177 Juniperus sabina Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000001840 diploid cell Anatomy 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229940124867 Poliovirus vaccine Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 201000006995 paralytic poliomyelitis Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
时间 | DO=30% | DO=50% | DO=70% |
0h | 3.92 | 4.50 | 4.17 |
6h | 4.00 | 4.58 | 4.42 |
12h | 4.50 | 5.21 | 4.79 |
18h | 5.21 | 6.12 | 5.71 |
24h | 5.79 | 6.62 | 6.25 |
30h | 6.17 | 6.88 | 6.50 |
36h | 6.54 | 7.63 | 7.29 |
42h | 7.25 | 8.92 | 8.21 |
48h | 6.75 | 9.25 | 8.54 |
54h | 6.38 | 9.71 | 8.75 |
60h | 5.83 | 9.38 | 8.46 |
66h | 5.37 | 8.75 | 7.79 |
72h | 5.09 | 8.25 | 7.41 |
时间 | DO=30% | DO=50% | DO=70% |
0h | 4.71 | 5.08 | 4.88 |
6h | 4.96 | 5.25 | 5.04 |
12h | 5.25 | 6.50 | 5.96 |
18h | 6.50 | 7.08 | 6.88 |
24h | 7.00 | 7.88 | 7.54 |
30h | 7.25 | 8.25 | 7.87 |
36h | 7.33 | 8.38 | 8.08 |
42h | 6.50 | 8.71 | 8.54 |
48h | 6.25 | 8.88 | 8.13 |
54h | 6.12 | 8.96 | 8.00 |
60h | 6.00 | 8.50 | 8.17 |
66h | 5.38 | 8.25 | 8.25 |
72h | 5.04 | 7.96 | 7.50 |
时间 | DO=30% | DO=50% | DO=70% |
0h | 4.12 | 4.88 | 4.50 |
6h | 4.38 | 5.08 | 4.88 |
12h | 5.00 | 5.75 | 5.50 |
18h | 5.25 | 6.46 | 6.17 |
24h | 5.88 | 7.25 | 6.96 |
30h | 6.25 | 7.50 | 7.25 |
36h | 6.88 | 8.54 | 8.17 |
42h | 7.50 | 8.96 | 8.75 |
48h | 7.12 | 9.87 | 9.50 |
54h | 6.79 | 10.25 | 9.67 |
60h | 6.21 | 9.501 | 9.25 |
66h | 5.87 | 9.00 | 8.75 |
72h | 5.17 | 7.71 | 7.04 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410570519.3A CN104312981B (zh) | 2014-10-23 | 2014-10-23 | 脊髓灰质炎灭活疫苗及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410570519.3A CN104312981B (zh) | 2014-10-23 | 2014-10-23 | 脊髓灰质炎灭活疫苗及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104312981A true CN104312981A (zh) | 2015-01-28 |
CN104312981B CN104312981B (zh) | 2017-09-19 |
Family
ID=52368297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410570519.3A Active CN104312981B (zh) | 2014-10-23 | 2014-10-23 | 脊髓灰质炎灭活疫苗及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104312981B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113227349A (zh) * | 2018-10-19 | 2021-08-06 | 尤尼沃尔塞尔斯技术股份公司 | 净化生物分子生产系统的方法及适用于净化的系统 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111662881B (zh) * | 2020-06-12 | 2021-06-18 | 北京生物制品研究所有限责任公司 | 新型冠状病毒Vero细胞灭活疫苗病毒液及其生产方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616096A (zh) * | 2004-09-16 | 2005-05-18 | 中国医学科学院医学生物学研究所 | 减毒株脊髓灰质炎灭活疫苗培养方法 |
CN1647822A (zh) * | 2005-02-06 | 2005-08-03 | 北京生物制品研究所 | 脊髓灰质炎灭活疫苗及其制备方法 |
CN102743749A (zh) * | 2012-06-15 | 2012-10-24 | 北京天坛生物制品股份有限公司 | 应用篮式生物反应器制备人二倍体细胞风疹减毒活疫苗的方法 |
-
2014
- 2014-10-23 CN CN201410570519.3A patent/CN104312981B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616096A (zh) * | 2004-09-16 | 2005-05-18 | 中国医学科学院医学生物学研究所 | 减毒株脊髓灰质炎灭活疫苗培养方法 |
CN1647822A (zh) * | 2005-02-06 | 2005-08-03 | 北京生物制品研究所 | 脊髓灰质炎灭活疫苗及其制备方法 |
CN102743749A (zh) * | 2012-06-15 | 2012-10-24 | 北京天坛生物制品股份有限公司 | 应用篮式生物反应器制备人二倍体细胞风疹减毒活疫苗的方法 |
Non-Patent Citations (2)
Title |
---|
张晋等: "篮式生物反应器制备Vero细胞乙型脑炎灭活疫苗", 《中国生物制品学杂志》 * |
薛英等: "不同培养基及不同的葡萄糖浓度对VERO细胞生长状况的影响", 《草食家畜》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113227349A (zh) * | 2018-10-19 | 2021-08-06 | 尤尼沃尔塞尔斯技术股份公司 | 净化生物分子生产系统的方法及适用于净化的系统 |
Also Published As
Publication number | Publication date |
---|---|
CN104312981B (zh) | 2017-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106047821B (zh) | 一种利用生物反应器规模化生产轮状病毒疫苗的方法 | |
US11629338B2 (en) | Method for acclimating and suspending Vero and second order production process for virus | |
CN104862267A (zh) | 适应于无血清培养和悬浮培养的mdck来源的细胞系与利用该细胞制备疫苗病毒的方法 | |
CN105969737B (zh) | 一种规模化生产轮状病毒疫苗的方法 | |
CN108570445A (zh) | Pk15细胞驯化悬浮方法和二阶病毒生产工艺 | |
CN102911910A (zh) | 人胚肺成纤维细胞株及利用其生产手足口病毒疫苗的方法 | |
CN102133398A (zh) | 应用生物反应器工业化生产动物流感疫苗的方法 | |
CN103394081B (zh) | 利用wave波浪生物反应器生产禽流感疫苗的方法 | |
CN109913404A (zh) | 鸡传染性法氏囊病毒活疫苗的制备方法 | |
CN102660510B (zh) | 一种利用生物反应器生产猪传染性胃肠炎病毒的方法 | |
CN105749270A (zh) | 轮状病毒疫苗及其制备方法 | |
CN104027798B (zh) | 一种全悬浮细胞培养生产猪圆环病毒2型抗原的方法 | |
CN104894054B (zh) | 一种猴胚胎肾上皮细胞Marc‑145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
CN105838683A (zh) | 一种应用新型细胞微载体增殖水貂犬瘟热病毒的方法 | |
CN104312981A (zh) | 脊髓灰质炎灭活疫苗及其生产方法 | |
CN103923885B (zh) | 鸡传染性法氏囊病毒Vero细胞适应株及其应用 | |
CN103468650A (zh) | 人胚肺成纤维细胞株在制备狂犬灭活疫苗中的应用 | |
CN108853489B (zh) | 一种利用无血清培养基生产pedv弱毒疫苗的方法 | |
CN102743749B (zh) | 应用篮式生物反应器制备人二倍体细胞风疹减毒活疫苗的方法 | |
CN104593335A (zh) | 低血清培养Marc-145细胞生产猪繁殖与呼吸道综合征CH-1R株病毒的方法 | |
CN106676058A (zh) | 一种bhk21悬浮细胞高密度流加培养方法及其在口蹄疫病毒增殖中的应用 | |
CN109679900B (zh) | 禽流感疫苗的制备方法及其产品 | |
CN108815516B (zh) | 一种利用无血清培养基生产pedv灭活疫苗的方法 | |
CN112961837A (zh) | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 | |
CN106237324A (zh) | 一种使用全悬浮技术生产猪传染性胃肠炎疫苗的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170213 Address after: 100176 Beijing city in Western Beijing economic and Technological Development Zone, Road No. 18 building C Room 101 Applicant after: Beijing North health research Biological Products Co. Address before: 100176 economic and Technological Development Zone Beijing City Xihuan Road No. 18 building A room 126 Applicant before: Tiantan Biological Products Co., Ltd., Beijing |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room 205, 2nd floor, 4th building, 9th courtyard, Boxing No. 2 Road, Beijing Economic and Technological Development Zone, 100176 Patentee after: Beijing Biological Products Research Institute Co., Ltd. Address before: Room 101, 1st Floor, Block C, 18 West Ring South Road, Beijing Economic and Technological Development Zone, 100176 Patentee before: Beijing North health research Biological Products Co. |
|
CP03 | Change of name, title or address | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Hui Inventor after: Yang Xiaoming Inventor after: Zhao Yuxiu Inventor after: Li Ailing Inventor after: Liang Hongyang Inventor after: Liu Xiaojuan Inventor after: Zhao Shuo Inventor after: Dong Yuan Inventor after: Zeng Lingbing Inventor before: Wang Hui Inventor before: Zhao Yuxiu Inventor before: Li Ailing Inventor before: Liang Hongyang Inventor before: Liu Xiaojuan Inventor before: Zhao Shuo Inventor before: Dong Yuan Inventor before: Zeng Lingbing |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Hui Inventor after: Yang Xiaoming Inventor after: Zhao Yuxiu Inventor after: Li Ailing Inventor after: Liang Hongyang Inventor after: Liu Xiaojuan Inventor after: Zhao Shuo Inventor after: Dong Yuan Inventor after: Zeng Lingbing Inventor before: Wang Hui Inventor before: Zhao Yuxiu Inventor before: Li Ailing Inventor before: Liang Hongyang Inventor before: Liu Xiaojuan Inventor before: Zhao Shuo Inventor before: Dong Yuan Inventor before: Zeng Lingbing |
|
CB03 | Change of inventor or designer information |